UNCYNasdaq United States
Market cap
$138.883 M
$5.07 +0.40%
Close of 7 Aug 2026
Revenue
—
Not reported
Earnings
-$26.6M
Loss-making
Shares outstanding
25,237,782
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Unicycive Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.